Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay Meeting Abstract


Authors: Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Abstract Title: Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904539
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.e22160
Notes: Meeting Abstract: e22160 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Marc Ladanyi
    1326 Ladanyi
  3. Gregory J Riely
    599 Riely
  4. David Hyman
    354 Hyman
  5. Ahmet Zehir
    343 Zehir
  6. Michael Forman Berger
    765 Berger
  7. Maria Eugenia Arcila
    657 Arcila
  8. Mark Kris
    869 Kris
  9. Alexander Edward Drilon
    632 Drilon